Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Endocrinol Metab. 2005 Jul;90(7):3863-70. Epub 2005 Apr 6.

Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.

Author information

1
Department of Internal Medicine, Université de Sherbrooke, Endocrine Division, 3001 12th North Avenue, Sherbrooke, Quebec J1H 5N4, Canada. jp.baillargeon@usherbrooke.ca

Abstract

CONTEXT:

The long-term cardiovascular safety of widely used oral contraceptives (OCs) is still debated, and no meta-analysis assesses the modern use of OCs and the associated cardiovascular risks.

OBJECTIVE:

We aimed to assess the risk of cardiovascular diseases associated with current use of low-dose combined OCs.

DATA SOURCES:

All studies published between January 1980 and October 2002 were searched using MEDLINE, BIOSIS, and Scientific Citations.

STUDY SELECTION:

Original studies were selected independently by two investigators (J.P.B., P.A.E.) based on inclusion criteria: low-dose combined OC (<50 mug of ethinyl-estradiol); more than 10 cases in low-dose users; clear definition of cases; concurrent controls; and control for age. A third investigator (J.E.N.) adjudicated disagreements. From 2715 identified articles, 14 independent studies were included.

DATA EXTRACTION:

All data were abstracted by one investigator (J.P.B.) in a systematic manner. Classification of OCs and types of exposure were directly abstracted from studies. Current use was defined as use at the time of the event or within 3 months. Only peer-reviewed studies with definition of events as definite or possible, based on prespecified criteria, were included.

DATA SYNTHESIS:

The summary risk estimates associated with current use of low-dose OCs were 1.84 [95% confidence interval (CI) = 1.38, 2.44] for myocardial infarctions and 2.12 (95% CI = 1.56, 2.86) for ischemic strokes. The overall summary odds ratio for both outcomes was 2.01 (95% CI = 1.63, 2.48). Second generation OCs were associated with a significant increased risk of both myocardial infarction and ischemic stroke events [1.85 (95% CI = 1.03,3.32) and 2.54 (95% CI = 1.96,3.28), respectively]; and third-generation OCs, for ischemic stroke outcome only [2.03 (95% CI = 1.15,3.57)].

CONCLUSIONS:

In conclusion, a rigorous meta-analysis of the literature suggests that current use of low-dose OCs significantly increases the risk of both cardiac and vascular arterial events, including a significant risk of vascular arterial complications with third generation OCs.

PMID:
15814774
DOI:
10.1210/jc.2004-1958
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center